These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37634598)

  • 1. Treatment with S-adenosylmethionine ameliorates irinotecan-induced intestinal barrier dysfunction and intestinal microbial disorder in mice.
    Xiao L; Dou W; Wang Y; Deng H; Xu H; Pan Y
    Biochem Pharmacol; 2023 Oct; 216():115752. PubMed ID: 37634598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice.
    Wang Y; Sun L; Chen S; Guo S; Yue T; Hou Q; Feng M; Xu H; Liu Y; Wang P; Pan Y
    Life Sci; 2019 Aug; 231():116529. PubMed ID: 31173781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
    Ye X; Sun M
    Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxifolin ameliorates lipopolysaccharide-induced intestinal epithelial barrier dysfunction via attenuating NF-kappa B/MLCK pathway in a Caco-2 cell monolayer model.
    Gong S; Zheng J; Zhang J; Wang Y; Xie Z; Wang Y; Han J
    Food Res Int; 2022 Aug; 158():111502. PubMed ID: 35840209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Escherichia coli Nissle 1917 Protects Intestinal Barrier Function by Inhibiting NF-
    Guo S; Chen S; Ma J; Ma Y; Zhu J; Ma Y; Liu Y; Wang P; Pan Y
    Mediators Inflamm; 2019; 2019():5796491. PubMed ID: 31354386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretions of Bifidobacterium infantis and Lactobacillus acidophilus Protect Intestinal Epithelial Barrier Function.
    Guo S; Gillingham T; Guo Y; Meng D; Zhu W; Walker WA; Ganguli K
    J Pediatr Gastroenterol Nutr; 2017 Mar; 64(3):404-412. PubMed ID: 28230606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
    Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
    Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells.
    Beutheu S; Ghouzali I; Galas L; Déchelotte P; Coëffier M
    Clin Nutr; 2013 Oct; 32(5):863-9. PubMed ID: 23428392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
    Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
    Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salmosan, a β-Galactomannan-Rich Product, Protects Epithelial Barrier Function in Caco-2 Cells Infected by Salmonella enterica Serovar Enteritidis.
    Brufau MT; Campo-Sabariz J; Bou R; Carné S; Brufau J; Vilà B; Marqués AM; Guardiola F; Ferrer R; Martín-Venegas R
    J Nutr; 2016 Aug; 146(8):1492-8. PubMed ID: 27358412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflatoxin B1 Induces Intestinal Barrier Dysfunction by Regulating the FXR-Mediated MLCK Signaling Pathway in Mice and in IPEC-J2 Cells.
    Liu S; Li J; Kang W; Li Y; Ge L; Liu D; Liu Y; Huang K
    J Agric Food Chem; 2023 Jan; 71(1):867-876. PubMed ID: 36579420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandrin C improves leaky gut conditions in intestinal cell monolayer, organoid, and nematode models by increasing tight junction protein expression.
    Kim MR; Cho SY; Lee HJ; Kim JY; Nguyen UTT; Ha NM; Choi KY; Cha KH; Kim JH; Kim WK; Kang K
    Phytomedicine; 2022 Aug; 103():154209. PubMed ID: 35689901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving Intestinal Barrier Function in Sepsis by Partially Hydrolysed Guar Gum via the Suppression of the NF-κB/MLCK Pathway.
    Tang Z; Zhu Y; Hu X; Lui K; Li S; Song X; Cai C; Guan X
    Mol Biotechnol; 2024 May; ():. PubMed ID: 38789715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy.
    Feng Y; Wang Y; Wang P; Huang Y; Wang F
    Cell Physiol Biochem; 2018; 49(1):190-205. PubMed ID: 30138914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers.
    Chen SW; Zhu J; Zuo S; Zhang JL; Chen ZY; Chen GW; Wang X; Pan YS; Liu YC; Wang PY
    Inflamm Res; 2015 Oct; 64(10):789-97. PubMed ID: 26249853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ganciclovir reduces irinotecan-induced intestinal toxicity by inhibiting NLRP3 activation.
    Huang H; Wang X; Zhang X; Zhang G; Jinbo M; Wang H; Yu P; Jiang W
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):195-204. PubMed ID: 31813002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daidzein Protects Caco-2 Cells against Lipopolysaccharide-Induced Intestinal Epithelial Barrier Injury by Suppressing PI3K/AKT and P38 Pathways.
    Zhang B; Wei X; Ding M; Luo Z; Tan X; Zheng Z
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Molecular Weight Fucoidan Restores Intestinal Integrity by Regulating Inflammation and Tight Junction Loss Induced by Methylglyoxal-Derived Hydroimidazolone-1.
    Lim JM; Yoo HJ; Lee KW
    Mar Drugs; 2022 Sep; 20(9):. PubMed ID: 36135768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.